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The surfactant sodium lauryl sulfate (SLS) and alkyldi­
methylbenzylammonium chloride (ADB) cause erythema 
and leukocyte infiltration on epicutaneous application. To 
elucidate the mechanism of this inflammatory response, the 
in vitro effect of the same agents was studied on human 
neutrophil migration, basophil histamine release, and leu­
kocyte lysosomal enzyme (f3-glucuronidase) release. At 
concentrations of greater than 0.02%, both surfactants were 
cytotoxic, as was evident by decreased eosin exclusion, 
massive histamine and f3-g1ucuronidase-release, and absent 
D etergents are well known irritants of the skin, and their effect on skin lipids and keratins, as well as their ability to penetrate through the epidermal bar­rier, have been well studied [1-31. Little is known, however, about the mechanisms by which these 
agents cause cutaneous inflammation. 
Several investigators have explained the irritative effects of de­
tergents by the capacity of the latter to denature proteins [1,4,5]. 
Harrold [4] measured the liberation of sulfhydril groups from 
callus material and found the greatest effect with sodium lauryl 
sulfate (SLS) and alkylbenzene sulfonate. Tronnier, Schuster, and 
Modde [6] found a good correlation between the irritation po­
tential of anionic surfactants in the rabbit eye and the inhibition 
of the enzyme saccharase in vitro. Imokawa [7-9] and Mishima 
documented, in a series of papers, that the irritative potential of 
a surfactant depends on its ability to labilize lysosomal mem­
branes. With the anionic detergents [alkyl (Cd-monophosphate 
and SLS] and a cationic detergent (alkyl trimethyl ammonium 
chloride), they found release of lysosomal enzymes from micro­
somal fractions. The action on lysosomes corresponded to the 
irritancy of human skin. The higher toxicity of cationic detergents 
in comparison to anionic detergents may be associated with their 
higher affinity to lysosomal membranes, because these generally 
have an anionic electrostatic charge [10]. 
Sodium lauryl sulfate and the cationic surfactant alkyldime­
thylbenzylammonium chloride (ADB), have been used previ­
ously for the assessment of human cutaneous irritability [11,12]. 
Upon occlusive application, these agents may cause erythema, 
edema, vesiculation, and pustulation at concentrations of 1-2%. 
Wahlberg and Maibach [13], using a rabbit model for evaluating 
the pustulogenic capacity of irritants, listed SLS to be positive in 
this test, together with other irritants such as croton oil and mer­
cury chloride. Since both surfactants, SLS and ADB, readily pen-
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migration of cells. At dilutions of less than 0.002% of both 
surfactants, viability of cells was normal, and small amounts 
of histamine and f3-g1ucuronidase were released at a dilu­
tion of 0.001 %. The most striking finding was a dose­
dependent chemotactic and chemokinetic response at di­
lutions from 10-3 to 10-8%. These observations offer a 
possible explanation for the pathomechanisms of irritant 
dermatitis due to surfactants. J Invest Dermatol 88: 52s-55s, 
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etrate into the dermis under occlusive conditions, they might elicit 
an inflammatory response by directly affecting leukocytes in the 
dermal microvasculature. To examine this possibility, we have 
studied the in vitro effect of SLS and ADB on human polymor­
phonuclear cell migration, and on the secretion of mediators of 
inflammation from these cells. 
MATERIALS AND METHODS 
Preparation of Cells Heparinized venous blood was obtained 
from healthy laboratory personnel or from patients with psoriasis, 
and was separated into mononuclear cells and polymorphonuclear 
cells (PMN) by Ficoll/Hypaque separation according to a mod­
ification of the methods ofB6yum [14, 15]. The PMN preparation 
contained 92-95% neutrophils and 1-4% basophils, the rest being 
lymphocytes. Cells were washed twice in Hank's buffer (Gibco, 
Glasgow, UK) before use. 
In vitro chemotaxis Polymorphonuclear cells (5 X 106), sus­
pended in 500 JLl Hank's buffer, containing 1 % human serum 
albumin (HSA) (Behringwerke, Marburg, FRG), were added to 
the upper compartment of a modified Boyden chamber, separated 
from the lower compartment by a 3-/-Lm pore size nitrocellulose 
filter (Sartorius, G6ttingen, FRG). The test solution (1. 2 ml) in 
Hank's HSA buffer was placed below the filter. Cells exposed to 
the buffer alone and to leukotriene B4 (L TB4) , 10-8 M (kindly 
donated by Dr. RJ Rokach, Montreal, Canada) served as controls 
in each experiment. After a 2-h incubation at 37°C and 7% CO2, 
the filters were removed, stained, cleared, and mounted. Cells 
were counted at the lower side of the filter in 5 random high­
power microscopic fields (HPF) (for details, see Czarnetzki [15]). 
Sodium lauryl sulfate (Fluka, Buchs, Switzerland) and ADB (n­
alkyl [50% C14, 40% C12, 10% C16] dimethylbenzylammonium 
chloride; Hyarnine® 3500, Rohm and Haas, Frankfurt,. FRG) were 
,dissolved in physiologic saline at 2%, and dilutions (10-3-10-8%) 
were made in Hank's buffer. 
Other Assays Histamine in cell supernatants was measured by 
a spectrofluorometric method after that of Shore [16], and {3-
glucuronidase ({3-G) after a modification of the method of Brit­
tinger [17], with phenolphthalein glucuronate as substrate. Re-
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Figure 1. Cell migration of neutrophils from two different donors (A 
and B) towards SLS and ADB. Note also the different sensitivity of donor 
cells toward the two surfactants. 
suits are expressed as percent release, compared with the total 
amount of histamine or enzyme in the lysed cell pellet. Viability 
of cells was assessed after microscopic evaluation of cells that had 
taken up the dye eosin Y (1 %) after a I-min incubation at room 
temperature. Results are expressed as the mean ± standard de­
viation of 4 or 5 different measurements. 
RESULTS 
The migratory behavior of PMN towards SLS and ADB was 
studied in 14 different donors. Representative data are shown in 
Fig 1, with the neutrophils of one patient being exposed to both 
substances at different concentrations in the lower compartment 
of the Boyden chambers. Migration was inhibited at very high 
concentrations and reached values above spontaneous migration 
in the presence of buffer at different dilutions of the stimuli. 
To analyze whether this migratory response was chemotactic 
or chemokinetic, checkerboard analyses were performed. Rep­
resentative data from cells of one patient each are shown in Table 
I. For SLS, maximal migration was reached at a dilution oflO-4o/0 
in the lower chamber. This exceeded by more than 10-fold the 
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spontaneous migration of cells in buffer alone. With SLS added 
to the cells in the upper chamber, migration was always lower 
than this value. A potent chemokinetic effect of SLS in both 
chambers, or of higher concentrations of SLS in the upper com­
pared to the lower chamber suppressed cell migration below buffer 
control. 
With ADB (Table I), maximal directed migration was also 
noted at a concentration of1O-4% and nondirected migration was 
seen at concentrations from 10-4 to 10-8%. Higher concentra­
tions of both SLS and ADB inhibited cell migration below the 
migration in buffer alone. 
Data from the other donors agreed with the checkerboard data 
shown (Table I) in that maximal directed migration occurred at 
10-4% in most patients, in only 1 patient at 10-30/0 and in 3 at 
10-5% for SLS. For ADB, 4 donor PMN migrated maximally 
at 10-3%, and most preparations had their maximum at 10-4 and 
10-50/0. Chemokinesis was seen with all donor PMN at lower 
concentrations of the surfactants. 
Compared with the migration of cells in the presence of buffer 
alone, the median increase by the activity of SLS and ADB was 
5-fold, with a maximum of 50-100-fold and a minimum of 24-
fold. Compared with the 10-8 M LTB4 standard, the surfactants 
caused twice as many PMN to move chemotactically at their 
maximal effect (range, 3 X to 0.2 X L TB4 effect). 
Table II shows the effect of preincubating PMN with SLS or 
ADB at 10-4 and 10-7%, or with buffer alone, followed by 
washing the cells twice and exposing them to the surfactants or 
buffer in the lower chemotaxis chamber. Migration of cells prein­
cubated with buffer alone was still evident at a dilution of 10-4% 
for both agents. Cells preincubated with SLS moved more ac­
tively towards SLS although spontaneous migration in the pres­
ence of buffer was decreased after preincubation with 10-4% SLS. 
Preincubation with ADB caused a decrease of directed and spon­
taneous migration at both concentrations. The results were con­
firmed with cells from two different donors. 
In a further set of experiments, PMN were examined for their 
viability, their histamine and {3-G release, and for the secretion 
of chemotactic activity after a 30-min incubation at various con­
centrations of SLS or ADB. At concentrations of greater than 
10-2% both surfactants were cytotoxic, as was evident by de­
creased viability and more than 70% histamine and f3-G release. 
Cell migration did not occur at these concentrations. At 10-30/0 
dilution (Table III), both surfactants caused a moderate histamine 
Table I. Checkerboard Studies on Effect of SLS and ADB on Human PMN Migration 
SLS Dilution SLS Dilution in Upper Compartment 
in Lower 
Compartment 
10-3 
10-4 
10-5 
10-6 
to-7 
to-8 
C 
ADB Dilution 
in Lower 
Compartment 
10-3 
to-4 
10-5 
to-6 
to-7 
10-8 
C 
to-3 
10-3 to-4 
to-5 10-(' to-7 
ADB Dilution in Upper Compartment 
to-5 10-6 to-7 
to-8 
to-8 
C 
530 
3000 
C 
Different dilutions (%) of the surfactants were added to the cells in the upper compartment of Boyden chambers. Data are expressed as cells that have migrated through 
the filter in 5 HPF. 
C = bu ffer control. 
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Table II. 
SLS Dilution 
in Lower 
Compartment 
10-4 
10-7 
C 
ADB Dilution 
in Lower 
Compartment 
10-4 
10-7 
C 
Effect of Preincubation of PMN for 30 min With 
the Surfactants 
Preincubation Dilution of SLS in Upper 
Compartment 
10-4 
273 ± 34 
4 ± 5 
10-7 
108 ± 13 
175 ± 24 
C 
275 ± 42 
61 ± 17 
83 ± 19 
Preincubation Dilution of ADB in Upper 
Compartment 
10-4 
o ± 0 
o ± 0 
10-7 
94 ± 15 
14 ± 4 
C 
150 ± 35 
118 ± 32 
105 ± 25 
PMN were preincubated with surfactants at 10-' or 10-70/0 dilution or in buffer 
alone (C). Cells were washed twice after this incubation. Note inactivation of cells 
with ADB at 10-4%. 
and f3-G release compared with spontaneous release, although cell 
viability was normal. Migration of different target cells towards 
the cell supernatants was increased in the Boyden assay (Table 
III). In the same assay, SDS and ADB alone, when added to the 
chambers at the same concentrations as they were present in the 
supernatants of stimulated cells, caused an even higher migration. 
Release of histamine or f3-G at concentrations of less than 10-3% 
dilution was not observed, while the supernatants continued to 
stimulate PMN migration, down to concentrations of 10-8% 
dilution. Again, this migration in response to cell supernatants 
was always slightly lower than that of the surfactant alone (not 
shown). 
DISCUSSION 
The data presented here show that these surfactants have profound 
effects on peripheral leukocytes at concentrations that have no 
cytotoxic effects. They enhance the random and directed migra­
tion of PMN at levels comparable to well-known potent che­
moattractants like L TB4, and they induce the secretion of pre­
formed mediators such as histamine and the lysosomal enzyme 
f3-G from the cells. 
The true chemotactic effect of surfactants is proven by the fact 
that the cells move in a concentration gradient in a dose-dependent 
fashion (Table I). Addition of high concentrations of the surfac­
tants to the cells reduces this migration, as occurs with other 
chemotactic factors. Under conditions where any gradient is lack­
ing, there is still migration of control cells, and the same holds 
when the surfactants are added to the cells in the upper chamber 
in the absence of stimulants in the lower chamber. This behavior 
of the cells is called chemokinesis [18,19]. 
The decreased ability of cells to respond to directed stimulation 
after preincubation with the stimulus is a typical property of 
chemotactic factors. The expected inhibition was only seen with 
Table III. Measurements of Cell Viability (Eosin Y 
Exclusion) and of Histamine, f3-G, and Chemotactic Activity 
in Cell Supernatants After Incubation With SLS, ADB, or 
Buffer Alone for 30 min, 37°C. 
Surfactant Histamine {3-G PMN 
(10-3% Viability release release chemotaxis 
dilution) (%) (%) (%) (ceUs/5 HPF) 
SLS 92 ± 3 39.1 ± 2.1 14 ± 4 82 ± 7 
ADB 91 ± 5 37.8 ± 3.4 10 ± 3 130 ± 15 
C 89 ± 3 12.2 ± 1.3 5 ± 1 53 ± 9 
C = buffer alone. 
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ADB but not with SLS (Table II). While the exact mechanism of 
this deactivation is not known, it might be related to surface 
receptors or to less specific effects on the cytoskeleton [20,21]. 
There are several possible explanations why deactivation was not 
observed w
.
ith SLS: (1) The chemokinetic effect of SLS might 
have outweIghed the chemotactic response in the cells and would 
thus enhance the readiness of the cells to respond. (2) The che­
mota�tic effect on SLS pretreated cells might be abolished by 
washmg the cells. (3) Because deactivation of cells depends on 
the duration of incubation, the optimal incubation time with SLS 
to see this effect might have been missed. It must however be 
emphasized that this deactivation is generally not considered a 
prerequisite to call a migratory response to a factor chemotactic 
or not. 
As is observed with many other chemotactic factors [23], SLS 
and ADB also induce a secretory response of cells at concentra­
tions that are noncytotoxic. Compared with the chemotactic and 
chemokinetic response, this occurs only over a very small range 
of concentrations, slightly below cytotoxic concentrations. 
Until now, chemotactic factors have been thought to stimulate 
cells via specific receptors. Such a specific binding structure has 
only been isolated for the neutrophil-chemotactic N-formyl-pep­
tides [24]. Our present findings suggest that a perturbation of the 
lipid bilayer of the membrane alone is enough to activate the 
complex intramembranous cascade of events that leads to a short­
ening of actin filaments and the subsequent cell migration. 
While the mechanisms of surfactant-induced chemotaxis are in 
need of further clarification on the cellular level, the present data 
provide an attractive explanation for the irritant, inflammatory 
effect of surfactants like SLS and ADB on the skin. The extremely 
low concentrations of the factors that might reach leukocytes in 
the dermal vasculature would cause these cells to migrate towards 
�he higher concentrations in the tissue. Lysosomal enzymes and, 
m the case of basophils (and mast cells), histamine would then 
elicit further inflammatory effects after the PMN are stimulated 
to �e�retion by the surfactants themselves or by their phagocytic 
aCtIVIty. 
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